Global Health (NSE:MEDANTA) EBIT : ₹7,010 Mil (TTM As of Mar. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Global Health EBIT?

Global Health's earnings before interest and taxes (EBIT) for the three months ended in Mar. 2024 was ₹1,613 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Mar. 2024 was ₹7,010 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Global Health's annualized ROC % for the quarter that ended in Mar. 2024 was 17.94%. Global Health's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2024 was 24.65%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Global Health's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2024 was 2.36%.

Global Health EBIT Historical Data

The historical data trend for Global Health's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Global Health EBIT Chart

Global Health Annual Data

Trend

Mar20

Mar21

Mar22

Mar23

Mar24

EBIT

1,148.52

995.65

3,600.43

5,272.09

7,010.12

Global Health Quarterly Data
	Mar20	Mar21	Jun21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
EBIT	Get a 7-Day Free Trial								1,535.59	1,589.58	1,906.93	1,900.44	1,613.17

Competitive Comparison of Global Health's EBIT

For the Medical Care Facilities subindustry, Global Health's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Global Health's EV-to-EBIT Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Global Health's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Global Health's EV-to-EBIT falls into.

Global Health EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹7,010 Mil.

Global Health (NSE:MEDANTA) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Global Health's annualized ROC % for the quarter that ended in Mar. 2024 is calculated as:

	ROC % (Q: Mar. 2024 )
=	NOPAT	/	Average Invested Capital
=	Operating Income * ( 1 - Tax Rate % )	/	( (Invested Capital (Q: Dec. 2023 )	+	Invested Capital (Q: Mar. 2024 ))	/ count )
=	6501.984 * ( 1 - 11% )	/	( (0	+	32263)	/ 1 )
=	5786.76576	/	32263
=	17.94 %

where

	Invested Capital		(Q: Dec. 2023 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	0	-	0	-	( 0	-	max(0, 0	-	0	+	0	))
=	0

	Invested Capital		(Q: Mar. 2024 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	43040.75	-	1867.78	-	( 12097.03	-	max(0, 6177.33	-	15087.3	+	12097.03	))
=	32263

Note: The Operating Income data used here is four times the quarterly (Mar. 2024) data.

2. Joel Greenblatt's definition of Return on Capital:

Global Health's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2024 is calculated as:

	ROC (Joel Greenblatt) %		(Q: Mar. 2024 )
=	EBIT	/	Average of (Net fixed Assets	+	Net Working Capital)
=	EBIT	/	Average of (Property, Plant and Equipment	+	Net Working Capital)
			Q: Dec. 2023		Q: Mar. 2024
=	EBIT	/	( ( (Property, Plant and Equipment + Net Working Capital)	+	(Property, Plant and Equipment + Net Working Capital) )	/	count )
=	6452.684	/	( ( (0 + max(0, 0))	+	(26179.03 + max(-1468.19, 0)) )	/	1 )
=	6452.684	/	( ( 0	+	26179.03 )	/	1 )
=	6452.684	/	26179.03
=	24.65 %

where Working Capital is:

	Working Capital		(Q: Dec. 2023 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(0	+	0	+	0)	-	(0	+	0	+	0)
=	0

	Working Capital		(Q: Mar. 2024 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(2153.13	+	668.5	+	168.64)	-	(1867.78	+	0	+	2590.68)
=	-1468.19

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Mar. 2024) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Global Health's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %	=	EBIT (TTM)	/	Enterprise Value (Q: Mar. 2024 )
	=	7010.12	/	297576.278
	=	2.36 %

Global Health EBIT Related Terms

Thank you for viewing the detailed overview of Global Health's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Global Health (NSE:MEDANTA) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Global Health Ltd (NSE:MEDANTA) » Definitions » EBIT

Comparable Companies

Traded in Other Exchanges

543654:India

Address

E - 18, Medanta - The Medicity, Defence Colony, New Delhi, IND, 110024

Website

https://www.medanta.org

Global Health Ltd operates as a private multi-specialty tertiary care provider operating in the North and East regions of India, with key specialties of cardiology and cardiac science, neurosciences, oncology, digestive and hepatobiliary sciences, orthopedics, liver transplant, and kidney and urology. Under the Medanta brand, it has a network of hospitals in operation (Gurugram, Indore, Ranchi, and Lucknow), a hospital that is under construction with an operational outpatient facility (Patna), and a hospital (Noida) planned for development. The Group operates Healthcare services as a single business segment in India, constituting a single geographical segment.

Global Health (NSE:MEDANTA) Headlines

No Headlines